AGEs act by modifying proteins or forming adducts with them (i.e., CML, pentosidine, or hydroimidazolone) through binding with AGE ligand-gated receptors, such as RAGE [39,70]. This evidence concerns the gene AGER and chronic myelogenous leukemia, BCR-ABL1 positive.